In line with the principle that inhibited expression of IL‐6 can produce an obvious anti‐inflammatory effect,12 it is expected by some researchers that IL‐6 blockers be used to treat cytokine release syndrome caused by COVID‐19,13 thus saving patients’ lives. Here, IL6 is linked to COVID-19.